Učitavanje...
The iontophoretic transdermal system formulation of sumatriptan as a new option in the acute treatment of migraine: a perspective
An iontophoretic transdermal system (ITS) (skin patch) formulation of sumatriptan for the acute treatment of migraine attacks was approved by the US Food and Drug Administration in January 2013. This transdermal system bypasses the gastrointestinal tract, as it uses low electrical current to move su...
Spremljeno u:
| Izdano u: | Ther Adv Neurol Disord |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4480530/ https://ncbi.nlm.nih.gov/pubmed/26136843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285615585918 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|